ArticleJournal of liver cancer2023

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.

Su Jong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.